John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), sold 288,500 shares at $2.10 ($606K) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Scheduled sale ($606k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.10 | 46,268 | $97K | 16.0% |
| 2 | $2.10 | 46,268 | $97K | 16.0% |
| 3 | $2.10 | 97,982 | $206K | 34.0% |
| 4 | $2.10 | 97,982 | $206K | 34.0% |
| Total | $2.10 avg | 288,500 | $606K | 100% |
| Filing → |
| AKBA | SELL | 2025-03-04 | $170K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |
| AKBA | SELL | 2024-02-29 | $115K | — | Filing → |